The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH 2024 | The pitfalls in genomics for myeloid malignancies
Thomas Coats, PhD, Royal Devon University Hospital Foundation Trust, Exeter, UK, briefly summarizes a session on the pitfalls in genomics for myeloid malignancies. The emergence of novel digital support tools and technologies, such as RNA fusion panels, will aid clinicians in accurately diagnosing and risk-stratifying patients. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
